Insider Trades57 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Sell | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 454 | $90.98 | $122.0B | -13.82% | +37.22% | $41.3K | -1.62% | — | Stalk |
| May 31, 2026 | Sell | CVS | Brian Newman | EVP, Chief Financial Officer | 2,478 | $90.98 | $122.0B | -13.82% | +37.22% | $225.4K | -45.17% | — | Stalk |
| May 31, 2026 | Sell | CVS | Amy Compton-Phillips | EVP, Chief Medical Officer | 7,618 | $90.98 | $122.0B | -13.82% | +37.22% | $693.1K | -44.36% | — | Stalk |
| May 8, 2026 | Sell | CVS | Tilak Mandadi | EVP, Chief Exp & Tech Officer | 69,551 | $89.58 | $122.0B | -13.82% | +37.22% | $6.2M | -87.28% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Amy Compton-Phillips | EVP, Chief Medical Officer | 5,569 | $71.82 | $122.0B | -13.82% | +37.22% | $400.0K | +6.26% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Heidi B Capozzi | EVP and Chief People Officer | 11,359 | $71.90 | $122.0B | -13.82% | +37.22% | $816.7K | +5.66% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 14,400 | $71.97 | $122.0B | -13.82% | +37.22% | $1.0M | +14.30% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Samrat S. Khichi | EVP, CPO and General Counsel | 16,072 | $71.97 | $122.0B | -13.82% | +37.22% | $1.2M | +6.27% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Brian Newman | EVP, Chief Financial Officer | 19,493 | $71.82 | $122.0B | -13.82% | +37.22% | $1.4M | +13.21% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Steven H Nelson | EVP and President, Aetna | 24,709 | $71.89 | $122.0B | -13.82% | +37.22% | $1.8M | +11.65% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Tilak Mandadi | EVP, Chief Exp & Tech Officer | 25,911 | $71.91 | $122.0B | -13.82% | +37.22% | $1.9M | +6.36% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | Prem S Shah | EVP and Group President | 26,546 | $71.86 | $122.0B | -13.82% | +37.22% | $1.9M | +8.89% | — | Stalk |
| Mar 31, 2026 | Buy | CVS | J. David Joyner | President, CEO and Chair | 94,355 | $71.88 | $122.0B | -13.82% | +37.22% | $6.8M | +51.20% | — | Stalk |
| Feb 28, 2026 | Sell | CVS | J. David Joyner | President and CEO | 1,944 | $79.90 | $122.0B | -13.82% | +37.22% | $155.3K | -3.74% | — | Stalk |
| Feb 28, 2026 | Sell | CVS | Samrat S. Khichi | EVP, CPO and General Counsel | 7,886 | $79.60 | $122.0B | -13.82% | +37.22% | $627.7K | -20.94% | — | Stalk |
| Jan 1, 2026 | Sell | CVS | Prem S Shah | EVP and Group President | 247 | $80.13 | $122.0B | -13.82% | +37.22% | $19.8K | -0.40% | — | Stalk |
| Dec 1, 2025 | Sell | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 220 | $79.10 | $122.0B | -13.82% | +37.22% | $17.4K | -0.89% | — | Stalk |
| Nov 30, 2025 | Sell | CVS | Tilak Mandadi | EVP, Chief Exp & Tech Officer | 6,575 | $80.36 | $122.0B | -13.82% | +37.22% | $528.4K | -8.15% | — | Stalk |
| Nov 30, 2025 | Sell | CVS | Heidi B Capozzi | EVP and Chief People Officer | 9,470 | $80.36 | $122.0B | -13.82% | +37.22% | $761.0K | -45.34% | — | Stalk |
| Aug 31, 2025 | Sell | CVS | Prem S Shah | EVP and Group President | 6,995 | $73.15 | $122.0B | -13.82% | +37.22% | $511.7K | -10.34% | — | Stalk |
| Aug 31, 2025 | Sell | CVS | Tilak Mandadi | EVP, Chief Exp & Tech Officer | 12,834 | $73.15 | $122.0B | -13.82% | +37.22% | $938.8K | -16.71% | — | Stalk |
| May 31, 2025 | Buy | CVS | Brian Newman | EVP, Chief Financial Officer | 21,861 | $64.04 | $122.0B | -13.82% | +37.22% | $1.4M | +23.06% | — | Stalk |
| May 31, 2025 | Buy | CVS | Amy Compton-Phillips | EVP, Chief Medical Officer | 53,091 | $64.04 | $122.0B | -13.82% | +37.22% | $3.4M | +71.82% | — | Stalk |
| Apr 1, 2025 | Sell | CVS | J. David Joyner | President and CEO | 1,847 | $67.98 | $122.0B | -13.82% | +37.22% | $125.6K | -0.66% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | Heidi B Capozzi | EVP and Chief People Officer | 11,768 | $67.98 | $122.0B | -13.82% | +37.22% | $800.0K | +8.82% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 16,976 | $67.98 | $122.0B | -13.82% | +37.22% | $1.2M | +52.95% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | Samrat S. Khichi | EVP, CPO and General Counsel | 17,729 | $67.98 | $122.0B | -13.82% | +37.22% | $1.2M | +12.48% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | Thomas F. Cowhey | EVP and CFO | 19,384 | $67.98 | $122.0B | -13.82% | +37.22% | $1.3M | +8.83% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | Steven H Nelson | EVP and President, Aetna | 21,329 | $67.98 | $122.0B | -13.82% | +37.22% | $1.4M | +23.58% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | Tilak Mandadi | EVP, Chief Experience & Tech | 21,589 | $67.98 | $122.0B | -13.82% | +37.22% | $1.5M | +8.62% | — | Stalk |
| Apr 1, 2025 | Buy | CVS | Prem S Shah | EVP and Group President | 27,786 | $67.98 | $122.0B | -13.82% | +37.22% | $1.9M | +13.07% | — | Stalk |
| Mar 17, 2025 | Buy | CVS | Prem S Shah | EVP and Group President | 846 | $62.21 | $122.0B | -13.82% | +37.22% | $52.6K | +2.00% | — | Stalk |
| Mar 5, 2025 | Sell | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 15,026 | $64.28 | $122.0B | -13.82% | +37.22% | $965.9K | +0.00% | — | Stalk |
| Feb 28, 2025 | Sell | CVS | J. David Joyner | President and CEO | 1,944 | $65.72 | $122.0B | -13.82% | +37.22% | $127.8K | -3.99% | — | Stalk |
| Feb 28, 2025 | Sell | CVS | Thomas F. Cowhey | EVP and CFO | 5,318 | $65.72 | $122.0B | -13.82% | +37.22% | $349.5K | -10.52% | — | Stalk |
| Feb 28, 2025 | Sell | CVS | Samrat S. Khichi | EVP, CPO and General Counsel | 5,604 | $65.72 | $122.0B | -13.82% | +37.22% | $368.3K | -21.80% | — | Stalk |
| Jan 23, 2025 | Buy | CVS | Steven H Nelson | EVP and President, Aetna | 24 | $53.70 | $122.0B | -13.82% | +37.22% | $1.3K | — | — | Stalk |
| Nov 30, 2024 | Sell | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 86 | $59.85 | $122.0B | -13.82% | +37.22% | $5.1K | -0.09% | — | Stalk |
| Nov 30, 2024 | Buy | CVS | Tilak Mandadi | EVP, Chief DDAT Officer | 50,125 | $59.85 | $122.0B | -13.82% | +37.22% | $3.0M | +23.42% | — | Stalk |
| Nov 30, 2024 | Buy | CVS | Heidi B Capozzi | EVP and Chief People Officer | 83,542 | $59.85 | $122.0B | -13.82% | +37.22% | $5.0M | — | — | Stalk |
| Sep 9, 2024 | Buy | CVS | Heidi B Capozzi | EVP and Chief People Officer | 80 | $57.36 | $122.0B | -13.82% | +37.22% | $4.6K | +84.21% | — | Stalk |
| Aug 31, 2024 | Sell | CVS | Tilak Mandadi | EVP, Chief Technology Officer | 13,097 | $57.24 | $122.0B | -13.82% | +37.22% | $749.7K | -24.48% | — | Stalk |
| Apr 1, 2024 | Sell | CVS | Thomas F. Cowhey | EVP and CFO | 1,719 | $79.56 | $122.0B | -13.82% | +37.22% | $136.8K | -1.72% | — | Stalk |
| Apr 1, 2024 | Sell | CVS | Prem S Shah | EVP and Pres-Pharm, Consumer W | 7,892 | $79.56 | $122.0B | -13.82% | +37.22% | $627.9K | -4.94% | — | Stalk |
| Apr 1, 2024 | Buy | CVS | Sreekanth K Chaguturu | EVP and Chief Medical Officer | 9,211 | $79.56 | $122.0B | -13.82% | +37.22% | $732.8K | +6.50% | — | Stalk |
| Apr 1, 2024 | Buy | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 13,687 | $79.56 | $122.0B | -13.82% | +37.22% | $1.1M | +30.11% | — | Stalk |
| Apr 1, 2024 | Buy | CVS | Laurie P. Havanec | EVP and Chief People Officer | 17,056 | $79.56 | $122.0B | -13.82% | +37.22% | $1.4M | +2.13% | — | Stalk |
| Apr 1, 2024 | Sell | CVS | Karen S Lynch | President and CEO | 107,201 | $79.56 | $122.0B | -13.82% | +37.22% | $8.5M | -5.14% | — | Stalk |
| Feb 28, 2024 | Sell | CVS | J. David Joyner | EVP&President-PharmacyServices | 1,970 | $75.19 | $122.0B | -13.82% | +37.22% | $148.1K | -2.08% | — | Stalk |
| Feb 28, 2024 | Sell | CVS | Thomas F. Cowhey | SVP, Interim CFO | 5,641 | $75.19 | $122.0B | -13.82% | +37.22% | $424.1K | -6.38% | — | Stalk |
| Feb 28, 2024 | Sell | CVS | Samrat S. Khichi | EVP, CPO and General Counsel | 6,210 | $75.19 | $122.0B | -13.82% | +37.22% | $466.9K | -7.50% | — | Stalk |
| Feb 26, 2024 | Sell | CVS | Prem S Shah | EVP and Pres-Pharm, Consumer W | 261 | $76.43 | $122.0B | -13.82% | +37.22% | $19.9K | -0.60% | — | Stalk |
| Feb 26, 2024 | Sell | CVS | Sreekanth K Chaguturu | EVP and Chief Medical Officer | 355 | $76.43 | $122.0B | -13.82% | +37.22% | $27.1K | -3.66% | — | Stalk |
| Feb 26, 2024 | Sell | CVS | Laurie P. Havanec | EVP and Chief People Officer | 6,698 | $76.43 | $122.0B | -13.82% | +37.22% | $511.9K | -12.91% | — | Stalk |
| Feb 16, 2024 | Sell | CVS | Prem S Shah | EVP and Pres-Pharm, Consumer W | 29,473 | $76.95 | $122.0B | -13.82% | +37.22% | $2.3M | -8.99% | — | Stalk |
| Dec 14, 2023 | Sell | CVS | James David Clark | SVP, Cont & Chief Acct Officer | 122 | $68.48 | $122.0B | -13.82% | +37.22% | $8.4K | -0.13% | — | Stalk |
| Nov 30, 2023 | Buy | CVS | Thomas F. Cowhey | SVP, Interim CFO | 7,358 | $67.95 | $122.0B | -13.82% | +37.22% | $500.0K | +6.83% | — | Stalk |